Literature DB >> 21191507

Should all men having a radical prostatectomy have a pelvic lymph node dissection? No.

Firas Abdollah1, Maxine Sun, Rodolphe Thuret, Pierre I Karakiewicz.   

Abstract

Entities:  

Year:  2010        PMID： 21191507      PMCID： PMC2997839          DOI： 10.5489/cuaj.964

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  18 in total

1.  Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy.

Authors:  Alberto Briganti; Felix K-H Chun; Andrea Salonia; Giuseppe Zanni; Vincenzo Scattoni; Luc Valiquette; Patrizio Rigatti; Francesco Montorsi; Pierre I Karakiewicz
Journal:  Eur Urol       Date:  2006-02-17       Impact factor: 20.096

2.  Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer.

Authors:  Sue A Joslyn; Badrinath R Konety
Journal:  Urology       Date:  2006-06-27       Impact factor: 2.649

3.  Prostate cancer and the Will Rogers phenomenon.

Authors:  Peter C Albertsen; James A Hanley; George H Barrows; David F Penson; Pam D H Kowalczyk; M Melinda Sanders; Judith Fine
Journal:  J Natl Cancer Inst       Date:  2005-09-07       Impact factor: 13.506

4.  Morbidity from pelvic lymphadenectomy in staging carcinoma of the prostate.

Authors:  D B Paul; S A Loening; A S Narayana; D A Culp
Journal:  J Urol       Date:  1983-06       Impact factor: 7.450

5.  Changing patterns of pelvic lymphadenectomy for prostate cancer: results from CaPSURE.

Authors:  Jun Kawakami; Maxwell V Meng; Natalia Sadetsky; David M Latini; Janeen Duchane; Peter R Carroll
Journal:  J Urol       Date:  2006-10       Impact factor: 7.450

6.  Laparoscopic pelvic lymph node dissection for prostate cancer: comparison of the extended and modified techniques.

Authors:  N N Stone; R G Stock; P Unger
Journal:  J Urol       Date:  1997-11       Impact factor: 7.450

7.  The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era.

Authors:  David S DiMarco; Horst Zincke; Thomas J Sebo; Jeffrey Slezak; Erik J Bergstralh; Michael L Blute
Journal:  J Urol       Date:  2005-04       Impact factor: 7.450

8.  The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer.

Authors:  Timothy A Masterson; Fernando J Bianco; Andrew J Vickers; Christopher J DiBlasio; Paul A Fearn; Farhang Rabbani; James A Eastham; Peter T Scardino
Journal:  J Urol       Date:  2006-04       Impact factor: 7.450

9.  Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

Authors:  A V D'Amico; R Whittington; S B Malkowicz; D Schultz; K Blank; G A Broderick; J E Tomaszewski; A A Renshaw; I Kaplan; C J Beard; A Wein
Journal:  JAMA       Date:  1998-09-16       Impact factor: 56.272

10.  A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.

Authors:  Ilias Cagiannos; Pierre Karakiewicz; James A Eastham; Makato Ohori; Farhang Rabbani; Claudia Gerigk; Victor Reuter; Markus Graefen; Peter G Hammerer; Andreas Erbersdobler; Hartwig Huland; Patrick Kupelian; Eric Klein; David I Quinn; Susan M Henshall; John J Grygiel; Robert L Sutherland; Phillip D Stricker; Christopher G Morash; Peter T Scardino; Michael W Kattan
Journal:  J Urol       Date:  2003-11       Impact factor: 7.450
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.